Residential Rehab Quality

• Approximately 320 specialized facilities with 13,200+ inpatient beds and ~220,000 patients treated annually, demonstrating substantial scale
• 68% 12-month abstinence rate in alcohol residential rehabilitation studies, exceeding the 40-60% 'good' range and meeting >60% effectiveness threshold
• Robust regulatory framework through DRV's mandatory quality assurance program, DEGEMED/FVS+ certification (DIN EN ISO 9001 adapted), deQus addiction-specific certification, and meine-rehabilitation.de public reporting portal
• Qualified clinical staff: psychotherapists require state Approbation (5+ year postgraduate training); psychiatrists hold medical board certification; dual-diagnosis care available for >50% of patients with comorbid psychiatric conditions
• Language barrier significantly limits international patient access: psychotherapy is 'almost universally conducted in German,' creating a fundamental clinical compromise for non-German speakers; no large-scale addiction centers built specifically for English-speaking medical tourists

Read the full Germany report →

• 40+ private residential facilities purpose-built for international patients, concentrated on Costa del Sol, Ibiza, Mallorca, and Canary Islands
• Leading facilities employ ICADC/FDAP-credentialled addiction specialists and board-certified psychiatrists with international training; Sea Recovery provides clinical services in 8 languages
• Evidence-based treatment modalities (CBT, DBT, ACT, MI, 12-Step Facilitation, EMDR, MAT) implemented across major facilities; dual-diagnosis programs explicitly offered
• No JCI or CARF facility-level accreditation confirmed; facilities hold regional health authority authorizations and WMA accreditation at some centers
• Claimed success rates 70-90% at select facilities; general evidence base suggests 40-60% for residential treatment completion; systematic national outcome reporting absent

Read the full Spain report →

• Two CARF-accredited facilities with evidence-based programs: NRC (January 2025 accreditation) and Erada (2023, plus Arab Board accreditation March 2025)
• Qualified psychiatric staff with international training: NRC teams trained with King's College London; Erada Director has 30+ years in addiction psychiatry; Ardens partnerships with Yale-affiliated Silver Hill Hospital and Caron Treatment Centers
• International patient services explicitly underdeveloped: no dedicated visa facilitation, translated aftercare documentation, or published international patient coordination protocols
• Severe capacity constraint: only 26 private residential beds available to international patients (17 at Ardens, 9 at Sakina); Erada's 210 beds serve primarily government-linked nationals and men only
• No published international patient outcomes: outcome data available only for nationals (NRC relapse rate 20% by 2010, 35.7% abstinence in 2024 study); gender segregation limits access for female international patients

Read the full United Arab Emirates report →

• Zero JCI or CARF international accreditations; facilities hold only domestic Ministry of Health or Ministry of Social Affairs licenses under Law 5753-1993
• At least 12 private residential facilities operate alongside 13 public residential detox centers; evidence-based treatment modalities documented include CBT, DBT, 12-step facilitation, somatic experiencing, and animal-assisted therapy across multiple centers
• Retorno operates dedicated English-language track with native English-speaking clinical staff; Phoenix provides multilingual services (English, Russian, Hebrew); IsraRehab provides Russian-language clinical team and extended online aftercare
• Clinical staff include psychiatrist-narcologists, PhD psychiatrists, and master's-level psychotherapists; Israeli psychiatrist licensing requires 4-year specialist residency plus formal examination
• Outcome transparency limited: Retorno reports 60–70% program completion; public sector averages 55% completion of three-week detox programs; no facility publishes independently audited long-term sobriety or relapse-prevention rates

Read the full Israel report →

• Samarpan Recovery holds CARF accreditation (only facility with this credential in Asia as of April 2025) and is a Gorski-CENAPS Centre of Clinical Excellence
• Multiple facilities (Athena Behavioral Health, Sanctum Wellness and Healing) hold NABH national accreditation; no JCI-accredited addiction facilities exist in India
• Premium facilities employ psychiatrists trained at AIIMS and NIMHANS with RCI-certified clinical psychologists and internationally trained therapists; government IRCA minimum standard is only bachelor's degree plus 6 months experience
• Approximately 40% of luxury facility patients are from overseas with dedicated international services (airport transfers, English/multilingual staff, NRI family protocols, aftercare continuity)
• Critical gap: No independently verified outcome data published; Abhasa self-reports 75% success rate without peer verification; Samarpan does not publicly publish aggregate sobriety rates
• Regulatory environment is weak with estimated 250-300 illegal de-addiction centers in Delhi alone, >50% of inspected facilities unlicensed at time of inspection, and documented cases of physical abuse and forced labor in mainstream sector

Read the full India report →

• Zero JCI/CARF international accreditation across all Polish residential addiction facilities; national CMJ accreditation dissolved January 2024
• Evidence-based treatment modalities implemented: CBT, DBT, EMDR, Seeking Safety model, 12-step integration; Reversed Addiction Clinic supervised by Harvard-affiliated US expert
• State-administered certification system through KCPU requiring master's degree, supervised practice, and biannual exams; new 4-year specialization pathway introduced 2023; 10 training units accredited
• Only 3-4 private facilities (Zeus, Reversed Addiction, The Road Back Home, Terapia Nałęczów) actively serve international patients; Zeus offers 10+ language support; public sector inaccessible to non-Polish speakers
• No national outcome-tracking system identified; no facility publishes clinical outcome data (sobriety rates, relapse prevention, follow-up results); PATQCN explicitly identifies inadequate quality monitoring as systemic gap

Read the full Poland report →

• Only 2 internationally CARF-accredited facilities identified: Oceánica and Monte Fénix (Oceánica - December 3, 2025 - https://oceanica-usa.com/)
• Evidence-based treatment approaches (CBT, DBT, motivational interviewing, 12-step facilitation) implemented at quality facilities (Mexican addiction clinics commonly use Cognitive Behavioral Therapy - residential_rehab_quality.md)
• Multidisciplinary clinical teams at professional facilities including addiction specialists, psychiatrists, nutritionists, and round-the-clock medical staff (Professional facilities like Oceánica - residential_rehab_quality.md)
• Bilingual international patient services with English-speaking staff at quality centers managing all logistics from airport pickup to departure (Many rehab centers cater specifically to foreign patients - residential_rehab_quality.md)
• Outcome data shows ~60% report significant improvements and ~40% maintain long-term abstinence with continuous support, with accredited facilities 20% higher success rates than non-accredited (According to SINAIS data and 2019 report - residential_rehab_quality.md)

Read the full Mexico report →

• Only NPISTANBUL Brain Hospital confirmed as JCI-accredited private facility with Addiction Center licensing from Ministry of Health
• No CARF (addiction-specific) accreditation identified for any Turkish facilities
• Treatment approaches include evidence-based modalities (CBT, DBT, medication-assisted treatment with Suboxone) at leading private facilities
• Nearly 50% of AMATEM inpatients return for additional treatment, indicating concerning relapse/return rates
• Limited transparency in outcome data; private facilities claim high success rates without published supporting evidence
• Multidisciplinary clinical teams (psychiatrists, psychologists, social workers, nurses) at accredited facilities
• English-speaking staff available with multilingual support (Arabic, Russian, German, French) for international patients
• Government Ministry of Health licensing and oversight present for both public AMATEM and private Addiction Centers
• Research identified gaps in professional licensing, accreditation, and professional standards affecting service quality

Read the full Turkey report →

• Zero JCI/CARF accreditation: No residential addiction facility in Malaysia holds international accreditation; Solace Asia holds NAADAC and NAATP credentials, which are below facility-level certification
• No published outcome data: Malaysian facilities do not publicly report long-term sobriety rates; available studies cite patient satisfaction but lack sustained recovery follow-up
• Small private sector: Approximately 3-4 quality facilities actively serve international patients, compared to dozens in competing markets like Thailand
• Evidence-based treatment confirmed: Solace Asia and other facilities implement CBT, DBT, motivational interviewing, EMDR, family therapy, and 12-step integration
• Recent regulatory framework and systemic failures: Mandatory registration began August 2025 (enforcement untested); March 2026 methamphetamine scandal at government facility indicates oversight gaps

Read the full Malaysia report →

• Zero JCI/CARF or equivalent international accreditation identified; private centers require no mandatory accreditation to operate
• All residential rehabilitation programs operate exclusively in Japanese with no dedicated international patient coordination at public facilities
• 36.7% perfect abstinence rate at 2 years post-residential treatment and ~40% relapse at 6 months demonstrate moderate outcomes
• Multiple evidence-based facilities (Kurihama Medical Center, Tokyo Metropolitan Matsuzawa Hospital, DARC network of 80+ sites) with qualified clinical staff for domestic patients
• Report explicitly states: 'Japan is not a functional destination for residential addiction treatment medical tourism'

Read the full Japan report →

• The Winslow is the only MOH-licensed private residential addiction treatment facility in Singapore, with no competitors or treatment choice available to international patients.
• Zero published outcome data: No Singapore private residential rehab facility reports sobriety rates, relapse prevention metrics, or longitudinal follow-up statistics, failing a core transparency requirement.
• No addiction-specific accreditation: The Winslow holds MOH licensing but not JCI or CARF addiction-specific accreditation; IMH/NAMS has JCI hospital accreditation but offers only 3-week inpatient care, well below international 30–90+ day residential standards.
• Mandatory drug-reporting law (Regulation 19) requires treating physicians to notify the CNB Director within seven days if they suspect drug addiction, overriding medical confidentiality and explicitly deterring international patients from seeking treatment in Singapore.
• Clinical excellence at The Winslow: Evidence-based neurocognitive treatment (EEG neurofeedback, ATT, cognitive remediation, MORE), leadership by Singapore's former National Chief of Addiction Medicine, 16-week continuum model, and comprehensive international patient coordination.

Read the full Singapore report →

• Zero international accreditation: no JCI, CARF, or HCAC-accredited addiction facilities identified
• Severe capacity crisis: 14,129 drug possession charges (2021) vs. ~100 voluntary residential treatment placements; facilities at full capacity
• No international patient services: no dedicated multilingual clinical staff, international coordination, or facilities marketing to foreign patients
• No published outcome data: zero sobriety rates, success metrics, or transparent reporting from any facility
• Critical staffing shortages: one psychiatrist per 75,000 citizens with documented brain drain to Gulf states
• Limited formalized treatment protocols: some evidence-based approaches documented but no published standards-compliance documentation

Read the full Jordan report →

• Zero international accreditation: no addiction-specific facility holds JCI or CARF certification despite 429 registered national facilities and 104 residential programs
• Staffing crisis: 60% of addiction treatment workers report being overwhelmed; only ~900 psychiatrists serve all Colombian mental health infrastructure; 33 of 318 facilities offer dual diagnosis treatment
• No outcome transparency: no residential facility publishes standardized outcome data; academic literature characterizes outcomes as 'poorly documented'
• Minimal international patient services: most facilities Spanish-only; no facility identified with dedicated international patient coordination; language barrier compromises intensive therapies
• Quality private exceptions: Fundación Evoluciona, Genesis Foundation Colombia, and ESE Hospital CARISMA demonstrate evidence-based care, but these are exceptions not representative of sector capacity

Read the full Colombia report →

• Zero international accreditation: no JCI or CARF-accredited addiction treatment facilities identified in Hungary
• No international patient services: all residential facilities operate in Hungarian only with no evidence of multilingual clinical staff or international patient coordination
• Limited outcome transparency: only one published completion rate (71.95% at Nyírő Gyula); no long-term sobriety rates or post-discharge outcome data available
• Explicit absence of quality assurance infrastructure despite heavy administrative oversight, according to peer-reviewed research on Hungary's mental health system
• Deteriorating policy environment: 2025 legislative reforms included constitutional prohibition on narcotics, shutdown of major harm reduction programs, and absence of replacement national drug strategy since 2020

Read the full Hungary report →

• Zero CARF/JCI or equivalent international accreditation: 'No Brazilian residential addiction rehabilitation facility holds CARF or JCI accreditation' and no facility appears in CARF international directory
• Complete absence of published outcome data: 'No facility in Brazil publishes residential addiction treatment outcomes, sobriety rates, or long-term follow-up data'
• Inadequate staff qualifications in dominant sector: Therapeutic communities 'predominantly use peer counselors and religious staff rather than licensed clinicians,' per IPEA research
• Minimal international patient services: 'English-language residential addiction treatment is available only at a small cluster of luxury boutique facilities in Florianópolis; the broader sector operates exclusively in Portuguese'
• Documented safety and human rights concerns: Therapeutic communities 'widely known...for human rights abuses including physical and psychological violence, forced labor, and religious freedom violations'

Read the full Brazil report →

• Only 6 rehabilitation centres in the country, with just 2 run by South Korea's government food and drug safety ministry
• 13 of 31 designated hospitals for drug addiction treatment treated zero patients, indicating severe systemic dysfunction
• Only 292 designated beds across 24 treatment institutions (fewer than 13 beds per facility on average)
• Designated hospitals cite 'lack of medical staff with drug addiction expertise' as the reason they cannot treat patients
• No international patient services specific to addiction treatment; language barriers prevent access to services requiring Korean proficiency
• Less than 2% of drug offenders participated in specialized addiction treatment in 2021, reflecting both limited capacity and social stigma
• No addiction-specific international accreditation (JCI-accredited facilities are general hospitals, not addiction treatment centers)

Read the full South Korea report →